Glucocorticoid resistance in inflammatory bowel disease

Journal of Endocrinology

Volumn 178, Issue 3, 2003, Pages 339-346

  Farrell, R J ^b   Kelleher, D ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOSPORIN; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN P; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISOLONE; STEROID; VALSPODAR;

ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; CROHN DISEASE; CUSHINGOID SYNDROME; CYTOPLASM; DOSE RESPONSE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; DRUG TISSUE LEVEL; ENTERITIS; FREQUENCY ANALYSIS; GASTROINTESTINAL SURGERY; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HORMONE RESPONSE; HORMONE TRANSPORT; HUMAN; INFLAMMATORY CELL; LIFESPAN; MULTIDRUG RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL; TREATMENT FAILURE; TREATMENT INDICATION; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS; CARRIER PROTEINS; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; GENES, MDR; HUMANS; INFLAMMATORY BOWEL DISEASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; T-LYMPHOCYTES; TREATMENT FAILURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141619279     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1780339     Document Type: Review

References (47)

1. Adcock IM, Lane SJ, Brown CR, Lee TH & Barnes PJ 1995 Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. Journal of Experimental Medicine 182 1951-1958.
2. Bamberger CM, Bamberger AM de Castro M & Chrousos GP 1995 Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. Journal of Clinical Investigation 95 2435-2441.
3. Bamberger CM, Else T, Bamberger AM, Beil FU & Schulte HM 1997 Regulation of the human interleukin-2 gene by the alpha and beta isoforms of the glucocorticoid receptor. Molecular Cell Endocrinology 136 23-28.
4. Bantel H, Domschke W & Schulz-Osthoff K 2000a Molecular mechanisms of glucocorticoid resistance. Gastroenterology 119 1178-1179.
5. Bantel H, Domschke W, Schulz-Osthoff K, Kaskas B & Gregor M 2000b Abnormal activation of transcription factor NF-kappaB involved in steroid resistance in chronic inflammatory bowel disease. American Journal of Gastroenterology 95 1845-1846.
6. Bantel H, Schmitz ML, Raible A, Gregor M & Schulze-Osthoff K 2002 Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB Journal 16 1832-1834.
7. Beato M, Herrlich P & Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83 851-857.
8. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U & Roots I 2001 Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clinical Pharmacology Therapy 69 169-174.
9. Chikanza IC 2002 Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. Annals of the New York Academy of Science 966 39-48.
10. Corrigan CJ 1996 Glucocorticoid-resistant asthma. Thymocyte defects. American Journal of Critical Care Medicine 154 553-555.
11. Cufer T, Vrhovec I, Pfeifer M, Skrk J, Borstnar S & Sikic BI 1998 Effect of the multidrug resistance modulator valspodar on serum cortisol levels in rabbits. Cancer Chemotherapy and Pharmacology 41 517-521.
12. Diaz-Borjon A, Richaud-Patin Y, Alvarado de la Barrera C, Jakez-Ocampo J, Ruiz-Arguelles A & Llorente L 2000 Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control. Joint Bone and Spine 67 40-48.
13. Dumont A, Helmer SP, Schmitz ML, Gustafsson JA, Liden J, Okret S, van der Saag PT, Wissink S, van der Burg B, Herrlich P, Haegeman G, De Bosscher K & Fiers W 1998 Cross-talk between steroids and NF-κB: what language? Trends in Biochemical Science 23 233-235.
14. Farrell RJ, Murphy A, Long A, Donnelly S, Cherikuri A, O'Toole D, Mahmud N, Keeling PW, Weir DG & Kelleher D 2000 High multidrug resistance (P-glycoprotein-170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118 279-288.
15. Farrell RJ, Menconi MJ, Keates AC & Kelly CP 2002 P-glycoprotein 170 inhibition significantly reduces cortisol and cyclosporin efflux from human intestinal epithelial cells and T-lymphocytes. Ailment Pharmacology Therapy 16 1021-1031.
16. Faubion WA Jr, Loftus EV, Harmsen WS, Zinsmeister AR & Sandborn WJ 2001 The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121 255-260.
17. Flood L, Lofberg R, Stierna P & Wikstrom AC 2001 Glucocorticoid receptor mRNA in patients with ulcerative colitis: a study of responders and nonresponders to glucocorticosteroid therapy. Inflammatory Bowel Disease 7 202-209.
18. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM & Pastan I 1987 Expression of a multidrug resistance gene in human tumors and tissues. PNAS 84 265-269.
19. Hearing SD, Norman M, Probert CS, Haslam N & Dayan CM 1999 Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45 382-388.
20. Hitzl M, Drescher S, van der Kuip H, Schaffeler E, Fischer J, Schwab M, Eichelbaum M & Fromm MF 2001 The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 11 293-298.
21. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M & Brinkmann U 2000 Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. PNAS 97 3473-3478.
22. Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T & Kohgo Y 2000 Expression of glucocorticoid receptor in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118 859-866.
23. Iida S, Gomi M, Moriwaki K, Itoh Y, Hirobe K, Matsuzawa Y, Katagiri S, Yonezawa T & Tarui S 1985 Primary cortisol resistance accompanied by a reduction in glucocorticoid receptors in two members of the same family. Journal of Clinical Endocrinology and Metabolism 60 967-971.
24. Kam JC, Szefler SJ, Surs W, Sher ER & Leung DY 1993 Combination IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T cell response to glucocorticoids. Journal of Immunology 151 3460-3466.
25. Kirkham BW, Corkill MM, Davison SC & Panayi GS 1991 Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses. Journal of Rheumatology 18 821-825.
26. Langhoff E, Ladefoged J, Jakobsen BK, Platz P, Ryder LP, Svejgaard A & Thaysen JH 1986 Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet 1 1296-1297.
27. Lazarowski A, Sevlever G, Taratuto A, Massaro M & Rabinowicz A 1999 Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy. Pediatric Neurology 21 731-734.
28. Leung DY, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP & Klemm DJ 1997 Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. Journal of Experimental Medicine 186 1567-1574.
29. Lindgren SC, Flood LM, Kilander AF, Lofberg R, Persson TB & Sjodahl RI 1998 Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. European Journal of Gastroenterology and Hepatology 10 831-835.
30. Loke TK, Sousa AR, Corrigan CJ & Lee TH 2002 Glucorticoid-resistant asthma. Current Allergy and Asthma Reports 2 144-150.
31. Lum BL & Gosland MP 1995 MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors. Hematology and Oncology Clinics of North America 9 319-336.
32. Maillefert JF, Maynadie M, Tebib JG, Aho S, Walker P, Chatard C, Dulieu V, Bouvier M, Carli PM & Tavernier C 1996 Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. British Journal of Rheumatology 35 430-435.
33. Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P & Schinkel AH 1997 Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. Journal of Clinical Investigation 100 2430-2436.
34. Montano E, Schmitz M, Blaser K & Simon HU 1996 P-glycoprotein expression in circulating blood leukocytes of patients with steroid-resistant asthma. Journal of Investigational Allergology and Clinical Immunology 6 14-21.
35. Munkholm P, Langholz E, Davidsen M & Binder V 1994 Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 35 360-362.
36. Oakley RH, Jewell CM, Yudt MR, Bofetiado DM & Cidlowski JA 1999 The dominant negative activity of the human glucocorticoid receptor β isoform. Specificity and mechanisms of action. Journal of Biological Chemistry 274 27857-27866.
37. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G & Cho JH 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 603-606.
38. Reinisch W, Gasche C, Wyatt J, Moser G, Lochs H, Vogelsang H & Gangl A 1995 Steroid dependency in Crohn's disease. Lancet 345 859.
39. Sandborn WJ, Landers CJ, Tremaine WJ & Targan SR 1996 Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clinic Proceedings 71 431-436.
40. Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Asante-Poku S, Zanger UM & Schwab M 2001 Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 358 383-384.
41. Scheinman RI, Cogwell PC, Lofquist AK & Baldwin Jr AS 1995 Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270 283-286.
42. Schinkel AH, Wagenaar E, van Deemter L, Mol CA & Borst P 1995 Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Journal of Clinical Investigation 96 1698-1705.
43. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE & Borst P 1997 Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. PNAS 94 4028-4033.
44. Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM & Raffel C 1995 MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36 1-6.
45. Vermeire S, Louis E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, Pescatore P, Fiasse R, Pelckmans P, Vlietinck R, Merlin F, Zouali H, Thomas G, Colombel JF & Hugot JP 2002 NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology 123 106-111.
46. Walker KB, Potter JM & House AK 1987 Interleukin 2 synthesis in the presence of steroids: a model of steroid resistance. Clinical and Experimental Immunology 68 162-167.
47. Zanker B, Barth C, Menges AV, Lammerding P, Stachowski J & Baldamus CA 1995 Expression of the MDR-1 in peripheral blood mononuclear cells from cyclosporin-treated renal transplant recipients rejecting their graft. Transplant Proceedings 27 925-926.